LC and LC-MS methods for the investigation of polypills for the treatment of cardiovascular diseases. Part 1. Separation of active components and classification of their interaction/degradation products

Journal of Pharmaceutical and Biomedical Analysis

Volumn 47, Issue 3, 2008, Pages 508-515

  Kumar, Vijay ^a   Shah, Ravi P ^a   Singh, Saranjit ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Aspirin; Atenolol; Atorvastatin; HPLC; Hydrochlorothiazide; LC MS; Lisinopril; Pravastatin; Simvastatin; Validation

Indexed keywords

ACETONITRILE; ACETYLSALICYLIC ACID; ATENOLOL; ATORVASTATIN; FORMIC ACID; HYDROCHLOROTHIAZIDE; LISINOPRIL; PHOSPHATE BUFFERED SALINE; PRAVASTATIN; SIMVASTATIN;

ACCURACY; ARTICLE; CARDIOVASCULAR DISEASE; DEGRADATION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; PH; PILL; PRIORITY JOURNAL; SEPARATION ANXIETY; SPECTRAL SENSITIVITY; TEMPERATURE;

ASPIRIN; ATENOLOL; CARDIOVASCULAR AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMBINATIONS; DRUG INTERACTIONS; DRUG STABILITY; HEPTANOIC ACIDS; HYDROCHLOROTHIAZIDE; LISINOPRIL; PRAVASTATIN; PYRROLES; SIMVASTATIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 43949139235     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.01.041     Document Type: Article

References (21)

1. Available from: http://www.who.int/cardiovascular_diseases/en/.
2. Available form: http://www.who.int/mediacentre/factsheets/fs317/en/index.html.
3. Elizabeth G., and Nabel M.D. N. Engl. J. Med. 349 (2003) 60-72
4. Sleight P., Pouleur H., and Zannad F. Eur. Heart J. 27 (2006) 1651-1656
5. Wald N.J., and Law M.R. Br. Med. J. 326 (2003) 1419-1428
6. Available from: http://www.medscape.com/viewarticle/471864.
7. Venkat Narayan K.M. Clin. Diabetes 22 (2004) 157-158
8. Fahey T., Brindle P., and Shah E. BMJ 330 (2005) 1035-1036
9. Available from: http://www.patentstorm.us/patents/4740373-description.html.
10. Gandhimathi M., Ravi T.K., Abraham A., and Thomas R. J. Pharm. Biomed. Anal. 32 (2003) 1145-1148
11. Kees F., Jehnich D., and Grobecker H. J. Chromatogr. B 677 (1996) 172-177
12. El-Gindy A., Emara S., and Mostafa A. Il Farmaco 60 (2005) 269-278
13. Modamio P., Lastra C.F., Montejo O., and Marifio E.L. Int. J. Pharm. 130 (1996) 137-140
14. Hertzog D.L., McCafferty J.F., Fang X., Tyrrell R.J., and Reed R.A. J. Pharm. Biomed. Anal. 30 (2002) 747-760
15. Franolic J.D., Lehr G.J., Barry T.L., and Petzinger G. J. Pharm. Biomed. Anal. 26 (2001) 651-663
16. Beasley C.A., Shaw J., Zhao Z., and Reed R.A. J. Pharm. Biomed. Anal. 37 (2005) 559-567
17. El-Emama A.A., Hansen S.H., Moustafa M.A., El-Ashry S.M., and El-Sherbiny D.T. J. Pharm. Biomed. Anal. 34 (2004) 35-44
18. Godoy R., Godoy C.G., Diego M.D., and Gomez C. Chil. Chem. Soc. 49 (2004) 289-289
19. Abu-Nameh E.S.M., Shawabkeh R.A., and Ali A. J. Anal. Chem. 61 (2006) 63-66
20. Erturk S., Aktas E.S., Ersoy L., and Fi{dotless}ci{dotless}ci{dotless}oglu S. J. Pharm. Biomed. Anal. 33 (2003) 1017-1023
21. Yang D.-J., and Hwang L.S. J. Chromatogr. A 1119 (2006) 277-284